These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7897548)

  • 1. Assessment of liver function: the current situation.
    Van Thiel DH; Hassanein T
    J Okla State Med Assoc; 1995 Jan; 88(1):11-6. PubMed ID: 7897548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the use of metabolic probes to quantify liver function: caffeine versus lidocaine.
    Ziebell J; Shaw-Stiffel T
    Dig Dis; 1995; 13(4):239-50. PubMed ID: 8521609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New methods for assessing liver function in infants and children.
    Balistreri WF; A-Kader HH; Setchell KD; Gremse D; Ryckman FC; Schroeder TJ
    Ann Clin Lab Sci; 1992; 22(3):162-74. PubMed ID: 1503384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic tests to study liver function.
    Burra P; Masier A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):19-21. PubMed ID: 15209151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver function assessment by drug metabolism.
    Barstow L; Small RE
    Pharmacotherapy; 1990; 10(4):280-8. PubMed ID: 2388874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Foreign substances as indicators of liver function].
    Preisig R
    Schweiz Med Wochenschr Suppl; 1985; 19():36-42. PubMed ID: 3864235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13C-breath tests in the study of microsomal liver function.
    Nista EC; Fini L; Armuzzi A; Candelli M; Zocco MA; Cazzato IA; Merra G; Finizio R; Miele L; Grieco A; Gasbarrini G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):33-46. PubMed ID: 15209153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine clearance study in hepatocellular carcinoma.
    Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiologic basis for clearance measurements in hepatology.
    Winkler K; Bass L; Keiding S; Tygstrup N
    Scand J Gastroenterol; 1979; 14(4):439-48. PubMed ID: 482856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug clearance as a decision aid for further invasive liver diagnosis--studies with hexobarbital as a model substrate].
    Zilly W; Richter E
    Z Gastroenterol; 1992 May; 30(5):325-8. PubMed ID: 1385917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aminopyrine breath test.
    Perri F; Pastore M; Annese V; Andriulli A
    Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
    Larrey D; Branch RA
    Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
    [No Abstract]   [Full Text] [Related]  

  • 17. Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function.
    Park GJ; Katelaris PH; Jones DB; Seow F; Le Couteur DG; Ngu MC
    Hepatology; 2003 Nov; 38(5):1227-36. PubMed ID: 14578861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].
    Perlík F; Pucelíková T; Slanar O
    Cas Lek Cesk; 2001 Feb; 140(2):51-3. PubMed ID: 11262908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing liver function.
    Sakka SG
    Curr Opin Crit Care; 2007 Apr; 13(2):207-14. PubMed ID: 17327744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to evaluate hepatic function: pharmacokinetic approach].
    Malè PJ
    Rev Med Suisse Romande; 1985 Apr; 105(4):313-6. PubMed ID: 4012141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.